10-23
HYPE Token Climbs 7% Following Hyperliquid Strategies' $888 Million Merger Completion
Hyperliquid's HYPE token rose 7.25% to $37.24 over 24 hours while Bitcoin fell 2.07% for the week to $108,848.27. Nasdaq-listed Sonnet BioTherapeutics completed an $888 million reverse merger with Rorschach I LLC on October 22, creating Hyperliquid Strategies Inc. The new entity holds approximately $583 million in HYPE tokens and plans to raise $1 billion through a 160-million-share offering to fund additional token acquisitions.
A
A+1.55%
10-23
10-23
Federal Reserve Proposes Restricted Master Accounts for Stablecoin Issuers
Federal Reserve Governor Christopher Waller directed staff to explore granting stablecoin firms limited access to Fed payment systems through restricted master accounts. The proposed framework would enable direct settlement on central bank infrastructure without traditional banking intermediaries. Speaking at the Fed's inaugural payment innovation conference, Waller acknowledged that distributed ledgers and crypto-assets have become integral to mainstream financial infrastructure.
AB
AB-1.88%
10-23
10-23
Hyperliquid Strategies Files to Raise $1 Billion for HYPE Token Acquisitions
Hyperliquid Strategies filed an S-1 registration statement with the SEC on Wednesday to raise up to $1 billion through a 160 million share offering. The company, formed from the merger of Nasdaq-listed Sonnet BioTherapeutics and Rorschach I LLC, plans to use proceeds for additional HYPE token purchases and corporate expenses. Upon completion, the entity will hold 12.6 million HYPE tokens valued at approximately $470 million, positioning it as the largest corporate holder of the token.
A
A+1.55%
10-23